Zoetis Hit With Class Action Lawsuit Alleging Misrepresentations on Vet Adoption Trends
ZTS is trading near its 52-week low of $72.38 (12% above the low).
Summary
A class action lawsuit has been filed against Zoetis Inc., alleging the company made misrepresentations about weakening veterinarian adoption and prescription trends for its key companion animal products. This legal action follows the significant stock decline on May 7, 2026, when Zoetis lowered its full-year 2026 guidance and disclosed deteriorating market conditions, as previously reported in news and SEC filings. The lawsuit introduces new legal and financial risk for Zoetis, potentially leading to future settlement costs or judgments. Investors have until July 27, 2026, to seek lead plaintiff status.
At the time of this announcement, ZTS was trading at $81.19 on NYSE in the Life Sciences sector, with a market capitalization of approximately $34.1B. The 52-week trading range was $72.38 to $168.83. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.